168 related articles for article (PubMed ID: 32639532)
21. New structural scaffolds for centrally acting oxime reactivators of phosphylated cholinesterases.
Sit RK; Radić Z; Gerardi V; Zhang L; Garcia E; Katalinić M; Amitai G; Kovarik Z; Fokin VV; Sharpless KB; Taylor P
J Biol Chem; 2011 Jun; 286(22):19422-30. PubMed ID: 21464125
[TBL] [Abstract][Full Text] [Related]
22. Counteracting tabun inhibition by reactivation by pyridinium aldoximes that interact with active center gorge mutants of acetylcholinesterase.
Kovarik Z; Maček Hrvat N; Kalisiak J; Katalinić M; Sit RK; Zorbaz T; Radić Z; Fokin VV; Sharpless KB; Taylor P
Toxicol Appl Pharmacol; 2019 Jun; 372():40-46. PubMed ID: 30978400
[TBL] [Abstract][Full Text] [Related]
23. Can hydroxylamine be a more potent nucleophile for the reactivation of tabun-inhibited AChE than prototype oxime drugs? An answer derived from quantum chemical and steered molecular dynamics studies.
Lo R; Ganguly B
Mol Biosyst; 2014 Jul; 10(9):2368-83. PubMed ID: 24964273
[TBL] [Abstract][Full Text] [Related]
24. Potent 3-Hydroxy-2-Pyridine Aldoxime Reactivators of Organophosphate-Inhibited Cholinesterases with Predicted Blood-Brain Barrier Penetration.
Zorbaz T; Braïki A; Maraković N; Renou J; de la Mora E; Maček Hrvat N; Katalinić M; Silman I; Sussman JL; Mercey G; Gomez C; Mougeot R; Pérez B; Baati R; Nachon F; Weik M; Jean L; Kovarik Z; Renard PY
Chemistry; 2018 Jul; 24(38):9675-9691. PubMed ID: 29672968
[TBL] [Abstract][Full Text] [Related]
25. Effect of reversible ligands on oxime-induced reactivation of sarin- and cyclosarin-inhibited human acetylcholinesterase.
Scheffel C; Thiermann H; Worek F
Toxicol Lett; 2015 Feb; 232(3):557-65. PubMed ID: 25522658
[TBL] [Abstract][Full Text] [Related]
26. Inhibition, reactivation and aging kinetics of cyclohexylmethylphosphonofluoridate-inhibited human cholinesterases.
Worek F; Eyer P; Szinicz L
Arch Toxicol; 1998 Sep; 72(9):580-7. PubMed ID: 9806430
[TBL] [Abstract][Full Text] [Related]
27. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J
Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
[TBL] [Abstract][Full Text] [Related]
28. Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun.
Carletti E; Aurbek N; Gillon E; Loiodice M; Nicolet Y; Fontecilla-Camps JC; Masson P; Thiermann H; Nachon F; Worek F
Biochem J; 2009 Jun; 421(1):97-106. PubMed ID: 19368529
[TBL] [Abstract][Full Text] [Related]
29. In vitro reactivation of acetylcholinesterase using the oxime K027.
Kuca K; Kassa J
Vet Hum Toxicol; 2004 Feb; 46(1):15-8. PubMed ID: 14748409
[TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of N-substituted-2-hydroxyiminoacetamides and interactions with cholinesterases.
Maraković N; Knežević A; Vinković V; Kovarik Z; Šinko G
Chem Biol Interact; 2016 Nov; 259(Pt B):122-132. PubMed ID: 27238725
[TBL] [Abstract][Full Text] [Related]
31. Reactivation of organophosphate-inhibited human acetylcholinesterase by isonitrosoacetone (MINA): a kinetic analysis.
Worek F; Thiermann H
Chem Biol Interact; 2011 Nov; 194(2-3):91-6. PubMed ID: 21930118
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
Shih TM; Skovira JW; O'Donnell JC; McDonough JH
Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
[TBL] [Abstract][Full Text] [Related]
33. Reactivation of cyclosarin-inhibited rat brain acetylcholinesterase by pyridinium--oximes.
Kuca K; Patocka J
J Enzyme Inhib Med Chem; 2004 Feb; 19(1):39-43. PubMed ID: 15202491
[TBL] [Abstract][Full Text] [Related]
34. The reactivation kinetic analysis, molecular docking, and dynamics of oximes against three V-type nerve agents inhibited four human cholinesterases.
Li K; Liu Y; Liu Y; Li Q; Guo L; Xie J
Chem Biol Interact; 2024 Jun; 396():111061. PubMed ID: 38763347
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and in vitro kinetic study of novel mono-pyridinium oximes as reactivators of organophosphorus (OP) inhibited human acetylcholinesterase (hAChE).
Valiveti AK; Bhalerao UM; Acharya J; Karade HN; Gundapu R; Halve AK; Kaushik MP
Chem Biol Interact; 2015 Jul; 237():125-32. PubMed ID: 26070418
[TBL] [Abstract][Full Text] [Related]
36. Potential of two new oximes in reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by organophosphate compounds: an in vitro study.
Costa MD; Freitas ML; Soares FA; Carratu VS; Brandão R
Toxicol In Vitro; 2011 Dec; 25(8):2120-3. PubMed ID: 21983245
[TBL] [Abstract][Full Text] [Related]
37. New Cinchona Oximes Evaluated as Reactivators of Acetylcholinesterase and Butyrylcholinesterase Inhibited by Organophosphorus Compounds.
Katalinić M; Zandona A; Ramić A; Zorbaz T; Primožič I; Kovarik Z
Molecules; 2017 Jul; 22(7):. PubMed ID: 28737687
[TBL] [Abstract][Full Text] [Related]
38. Amidine-oximes: reactivators for organophosphate exposure.
Kalisiak J; Ralph EC; Zhang J; Cashman JR
J Med Chem; 2011 May; 54(9):3319-30. PubMed ID: 21438612
[TBL] [Abstract][Full Text] [Related]
39. Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro.
Jun D; Musilova L; Kuca K; Kassa J; Bajgar J
Chem Biol Interact; 2008 Sep; 175(1-3):421-4. PubMed ID: 18617161
[TBL] [Abstract][Full Text] [Related]
40. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
